On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel Research, Prime Vitality, Summit...more
12/20/2024
/ Distributors ,
Drug Compounding ,
False Advertising ,
FDA Approval ,
FDA Warning Letters ,
Knockoffs ,
Labeling ,
Manufacturers ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Violations